Learning Objectives:

• Review patient clinical and pathology data in a multidisciplinary setting to determine the utility and impact of molecular testing on patient management.

• Provide guidance in identifying the most informative and appropriate molecular tests for each patient.

• Interpret molecular testing results with a multidisciplinary team to identify clinically actionable mutations and help the treating oncology team understand their significance.

• Identify potential non-standard treatment options, including off-label therapies, suitable clinical trials, or access to investigational drugs.

• Support the oncology team in acquiring identified therapies (e.g., providing documentation for insurance appeals).

• Determine if additional molecular or germline testing may be indicated for a comprehensive patient understanding.

• Serve as a platform for expert knowledge exchange and collaborative discussion across disciplines. • Provide ongoing education and improve understanding of tumor genetics, molecular biology, and emerging findings within the clinical community.